What are the Challenges in Developing Cancer Drug Candidates?
Developing cancer drug candidates is fraught with challenges. One major issue is the heterogeneity of cancer, meaning that different patients' tumors may respond differently to the same treatment. Additionally, cancer cells can develop resistance to therapies over time. There are also significant financial and time investments required for drug development, with many candidates failing to prove effective in clinical trials.
